Guillermo Villacampa

Articles by Guillermo Villacampa

12 TIP HARMONIA SOLTI-2101/ AFT-58: A Head-to-Head Phase III Study Comparing Ribociclib (RIB) and Palbociclib (PAL) in Patients (pts) With Hormone Receptor– Positive/HER2-Negative/HER2- Enriched (HR+/HER2−/HER2-E) Advanced Breast Cancer (ABC)

ByLisa A. Carey, MD,Tomas Pascual,Daniel Stover,Astrid Thuerigen,Charles Perou,Eva Ciruelos,Ana Casas,Patty Spears,Estelle Roux,Faye Su,Hullin Hu,Yen-Shen Lu,Sara M. Tolaney, MD, MPH,Ann H. Partridge, MD, MPH,Guillermo Villacampa,Juan Manuel Ferrero-Cafiero,Aleix Prat

April 28th 2023

Latest Updated Articles

Trending on CancerNetwork

Trastuzumab Botidotin Prolongs PFS vs T-DM1 in HER2+ Advanced Breast Cancer

Daraxonrasib Receives FDA Breakthrough Therapy Status in 1L Metastatic PDAC

IASO208 Receives FDA IND Clearance for Relapsed/Refractory B-Cell Lymphoma

How Does Azacitidine/Venetoclax Impact Hospital Burden in AML?

Novel Macrocyclic EGFR TKI Shows Responses in EGFR C797S–Positive NSCLC